BoneSupport Encouraged By Top-Line Data From CERTiFy Trial Of Cerament Bone Void Filler Injectable
Executive Summary
Results of the CERTiFy study demonstrate Bonesupport's Cerament bone-void filler is non-inferior to autograft in treating tibia plateau fracture defects. The company says the study marks a major milestone for its business and will change the standard of care for this kind of injury.